Swiss-based biopharmaceutical company AC Immune SA has announced peer-reviewed findings from its Phase 1b/2a trial, marking a significant step...
Lire la suiteSheffield Teaching Hospitals NHS Foundation Trust has been chosen as the United Kingdom’s only centre to take part in...
Lire la suiteAcella Pharmaceuticals, in collaboration with its sister company Neuvosyn Laboratories, has announced encouraging topline results from a phase 2...
Lire la suiteThe North Yorkshire-based artisan food manufacturer, The Original Baker, has completed a major expansion project at its North Malton...
Lire la suiteXeltis has announced highly successful results from its aXess EU phase 3 clinical trial, marking a major milestone in...
Lire la suiteModus Therapeutics will present new research findings on its investigational drug sevuparin for chronic kidney disease (CKD) with anemia...
Lire la suite